National Research Corporation $NRC Shares Purchased by Rhumbline Advisers

Rhumbline Advisers lifted its stake in National Research Corporation (NASDAQ:NRC) by 4.5% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 22,204 shares of the company’s stock after purchasing an additional 946 shares during the quarter. Rhumbline Advisers owned about 0.10% of National Research worth $284,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. AQR Capital Management LLC increased its holdings in shares of National Research by 168.6% in the first quarter. AQR Capital Management LLC now owns 108,134 shares of the company’s stock valued at $1,384,000 after purchasing an additional 67,882 shares during the last quarter. Envestnet Asset Management Inc. increased its holdings in shares of National Research by 23.1% in the first quarter. Envestnet Asset Management Inc. now owns 89,985 shares of the company’s stock valued at $1,152,000 after purchasing an additional 16,868 shares during the last quarter. Willis Investment Counsel increased its holdings in shares of National Research by 19.1% in the first quarter. Willis Investment Counsel now owns 65,778 shares of the company’s stock valued at $842,000 after purchasing an additional 10,531 shares during the last quarter. Jane Street Group LLC increased its holdings in shares of National Research by 394.2% in the first quarter. Jane Street Group LLC now owns 52,411 shares of the company’s stock valued at $671,000 after purchasing an additional 41,806 shares during the last quarter. Finally, American Century Companies Inc. increased its holdings in shares of National Research by 7.3% in the first quarter. American Century Companies Inc. now owns 42,102 shares of the company’s stock valued at $539,000 after purchasing an additional 2,848 shares during the last quarter. Institutional investors and hedge funds own 47.26% of the company’s stock.

National Research Price Performance

NASDAQ:NRC opened at $13.85 on Friday. The stock has a 50 day moving average price of $14.85 and a 200 day moving average price of $14.30. The company has a debt-to-equity ratio of 3.61, a quick ratio of 0.70 and a current ratio of 0.70. The stock has a market cap of $319.38 million, a PE ratio of 18.22 and a beta of 0.47. National Research Corporation has a one year low of $9.76 and a one year high of $22.99.

National Research (NASDAQ:NRC) last posted its earnings results on Monday, July 28th. The company reported $0.28 earnings per share (EPS) for the quarter. The company had revenue of $34.04 million during the quarter. National Research had a return on equity of 83.52% and a net margin of 12.78%.

National Research Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 10th. Shareholders of record on Friday, September 26th will be paid a dividend of $0.12 per share. The ex-dividend date of this dividend is Friday, September 26th. This represents a $0.48 annualized dividend and a yield of 3.5%. National Research’s dividend payout ratio (DPR) is 63.16%.

About National Research

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.